Cargando…

Body fatness and breast cancer risk in relation to phosphorylated mTOR expression in a sample of predominately Black women

BACKGROUND: The mechanistic target of rapamycin (mTOR) pathway promoted by positive energy imbalance and insulin-like growth factors can be a mechanism by which obesity influences breast cancer risk. We evaluated the associations of body fatness with the risk of breast cancer varied with phosphoryla...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Ting-Yuan David, Omilian, Angela R., Yao, Song, Zhang, Weizhou, Datta, Susmita, Bshara, Wiam, Ondracek, Rochelle Payne, Davis, Warren, Liu, Song, Hong, Chi-Chen, Bandera, Elisa V., Khoury, Thaer, Ambrosone, Christine B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8325192/ https://www.ncbi.nlm.nih.gov/pubmed/34330319 http://dx.doi.org/10.1186/s13058-021-01458-z

Ejemplares similares

Body fatness and mTOR pathway activation of breast cancer in the Women’s Circle of Health Study
por: Cheng, Ting-Yuan David, et al.
Publicado: (2020)

mTOR pathway gene expression in association with race and clinicopathological characteristics in Black and White breast cancer patients
por: Ilozumba, Mmadili N., et al.
Publicado: (2022)

Racial differences in CD8(+) T cell infiltration in breast tumors from Black and White women
por: Abdou, Yara, et al.
Publicado: (2020)

Association Between Recreational Physical Activity and mTOR Signaling Pathway Protein Expression in Breast Tumor Tissue
por: Cheng, Ting-Yuan David, et al.
Publicado: (2023)

Multiplexed digital spatial profiling of invasive breast tumors from Black and White women
por: Omilian, Angela R., et al.
Publicado: (2021)

Genetic Variants in COX2 and ALOX Genes and Breast Cancer Risk in White and Black Women
por: Mongiovi, Jennifer M., et al.
Publicado: (2021)

47982 Reversing the resistance to chemotherapy in White and Black patients with triple negative breast cancer (TNBC).
por: Gandhi, Shipra, et al.
Publicado: (2021)

DNA methylation differences in noncoding regions in ER negative breast tumors between Black and White women
por: Chen, Jianhong, et al.
Publicado: (2023)

Predominant Role of mTOR Signaling in Skin Diseases with Therapeutic Potential
por: Karagianni, Fani, et al.
Publicado: (2022)

Prognostic value of histone chaperone FACT subunits expression in breast cancer
por: Attwood, Kristopher, et al.
Publicado: (2017)

Frequency of breast cancer subtypes among African American women in the AMBER consortium
por: Allott, Emma H., et al.
Publicado: (2018)

Results and lessons from dual extraction of DNA and RNA from formalin-fixed paraffin-embedded breast tumor tissues for a large Cancer epidemiologic study
por: Ondracek, Rochelle Payne, et al.
Publicado: (2022)

mTOR-dependent phosphorylation controls TFEB nuclear export
por: Napolitano, Gennaro, et al.
Publicado: (2018)

Intratumoral heterogeneity as a source of discordance in breast cancer biomarker classification
por: Allott, Emma H., et al.
Publicado: (2016)

Phosphorylated Mammalian Target of Rapamycin p-mTOR Is a Favorable Prognostic Factor than mTOR in Gastric Cancer
por: Cao, Guo-dong, et al.
Publicado: (2016)

Glutamate transporter-dependent mTOR phosphorylation in Müller glia cells
por: María López-Colomé, Ana, et al.
Publicado: (2012)

Phosphorylated mTOR Expression Profiles in Human Normal and Carcinoma Tissues
por: Lee, Hojung
Publicado: (2017)

Phosphorylation of the novel mTOR substrate Unkempt regulates cellular morphogenesis
por: Baskaran, Pranetha, et al.
Publicado: (2022)

Immunohistochemical analysis of adipokine and adipokine receptor expression in the breast tumor microenvironment: associations of lower leptin receptor expression with estrogen receptor-negative status and triple-negative subtype
por: Llanos, Adana A. M., et al.
Publicado: (2020)

PLD1 regulates adipogenic differentiation through mTOR - IRS-1 phosphorylation at serine 636/639
por: Song, Hae-In, et al.
Publicado: (2016)

Temporal changes in mammalian target of rapamycin (mTOR) and phosphorylated-mTOR expressions in the hippocampal CA1 region of rat with vascular dementia
por: Park, Jin-A, et al.
Publicado: (2017)

Dual Target of EGFR and mTOR Suppresses Triple-Negative Breast Cancer Cell Growth by Regulating the Phosphorylation of mTOR Downstream Proteins
por: Ma, Jing, et al.
Publicado: (2023)

Platelet-derived growth factor-induced Akt phosphorylation requires mTOR/Rictor and phospholipase C-γ1, whereas S6 phosphorylation depends on mTOR/Raptor and phospholipase D
por: Razmara, Masoud, et al.
Publicado: (2013)

Clinicopathological and prognostic significance of mTOR and phosphorylated mTOR expression in patients with esophageal squamous cell carcinoma: a systematic review and meta-analysis
por: Li, Shuangjiang, et al.
Publicado: (2016)

PRAME expression and promoter hypomethylation in epithelial ovarian cancer
por: Zhang, Wa, et al.
Publicado: (2016)

Risk factors for estrogen receptor positive ductal carcinoma in situ of the breast in African American women
por: Bertrand, Kimberly A., et al.
Publicado: (2019)

mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer
por: Gao, Wei, et al.
Publicado: (2012)

Endocrine responses and acute mTOR pathway phosphorylation to resistance exercise with leucine and whey
por: Lane, MT, et al.
Publicado: (2017)

Systematic Screen for Drosophila Transcriptional Regulators Phosphorylated in Response to Insulin/mTOR Pathway
por: Liu, Ying, et al.
Publicado: (2020)

Tyrosine phosphorylation of DEPTOR functions as a molecular switch to activate mTOR signaling
por: M. Gagné, Laurence, et al.
Publicado: (2021)

mTOR-mediated phosphorylation of VAMP8 and SCFD1 regulates autophagosome maturation
por: Huang, Hong, et al.
Publicado: (2021)

MLXIPL promotes the migration, invasion, and glycolysis of hepatocellular carcinoma cells by phosphorylation of mTOR
por: Chang, Xiaowei, et al.
Publicado: (2023)

Saikosaponin-d increases radiation-induced apoptosis of hepatoma cells by promoting autophagy via inhibiting mTOR phosphorylation
por: Wang, Baofeng, et al.
Publicado: (2021)

Myelination and mTOR
por: Figlia, Gianluca, et al.
Publicado: (2017)

Real-Life Experience of mTOR Inhibitors in Liver Transplant Recipients in a Region Where Living Donation Is Predominant
por: Sung, Pil Soo, et al.
Publicado: (2021)

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
por: Zou, Zhilin, et al.
Publicado: (2020)

mTOR kinase leads to PTEN-loss-induced cellular senescence by phosphorylating p53
por: Jung, Seung Hee, et al.
Publicado: (2018)

Histone demethylase JMJD1C is phosphorylated by mTOR to activate de novo lipogenesis
por: Viscarra, Jose A., et al.
Publicado: (2020)

Turnover of the mTOR inhibitor, DEPTOR, and downstream AKT phosphorylation in multiple myeloma cells, is dependent on ERK1-mediated phosphorylation
por: Vega, Mario, et al.
Publicado: (2022)

mTOR Signaling in Cancer and mTOR Inhibitors in Solid Tumor Targeting Therapy
por: Tian, Tian, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_t5rs2kdbe6q5t0vt1i7buccksd